MeTA - Zambia

Zambia is one of the seven countries taking part in the pilot phase of MeTA. The resources listed below relate specifically to Zambia.

We will add to this key list over time and would welcome suggestions or additions. Please send these to:

Selected resources

Books, reports, etc

Impact of public-private partnerships addressing access to pharmaceuticals in low and middle income countries : A synthesis report from studies in Botswana, Sri Lanka, Uganda and Zambia

LUSH, Louisiana
September 2004

Expand view

This report provides an overview, with general conclusions and recommendations, from a series of studies in Uganda (the pilot country) plus Botswana, Sri Lanka and Zambia, designed to assess the health and health systems impact of public-private partnerships for improving access to pharmaceuticals in relation to tropical diseases and/or HIV and AIDS, where pharmaceutical companies are involved as partners in supplying free or discounted drugs

Missing the target #5 : improving AIDS drug access and advancing health care for all

December 2007

Expand view

This report documents how the mobilisation around AIDS is driving health systems advancement in China, Dominican Republic, Zimbabwe, Russia, Kenya, India, Cameroon, Zambia and Cambodia, and it highlights the need for improvements in broader systems of care and services to meet the needs of people living with HIV & AIDS and the communities in which they live. It also considers ARV procurement, registration and stock-outs in Argentina, Belize, Cambodia, China, Dominican Republic, India, Malawi, Morocco, Nigeria, Philippines, Russia, Uganda, Zambia, Zimbabwe

Pain relieving drugs in 12 African PEPFAR countries : mapping current providers, identifying current challenges, and enabling expansion of pain control provision in the management of HIV/AIDS

HARDING, Richard
et al
January 2007

Expand view

This study aims to identify current opioid prescribing services and regulatory bodies within 12 African PEPFAR (Presidents Emergency Plan for AIDS Relief ) countries, and to examine the barriers to, and appraise the potential for, expansion in the number of opioid providers, for people with HIV and AIDS according to the World Health Organization pain ladder. It concludes that while there are common issues raised by services and International Narcotics Control Board competent authorities, it is clear that these key stakeholders have concerns regarding the potential roll-out of opioids

Seizing the opportunity on AIDS and health systems

OOMMAN, Nandini
August 2008

Expand view

This is a comparison of donor interactions with national health systems in Mozambique, Uganda, and Zambia - specifically: the health information systems, the supply chain systems for essential medicines, and human resources for health. It focuses on the US President’s Emergency Plan for AIDS Relief, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank’s Africa Multi-Country AIDS Program

Understanding the private sector anti-malarial market in Zambia

June 2008

Expand view

These are the findings of a rapid analysis of private retail and wholesale outlets in six districts of Zambia to guide ongoing deliberations on a national private sector artemisinin-based combination therapies (ACTs) subsidy. Despite being one of the first countries to adopt ACTs, access to these treatments in Zambia has remained low, reaching only eight per cent of children under five within 24 hours in 2006. The accompanying file contains maps of the six districts - Choma, Kabwe, Kafue, Lundazi, Mwense and Samfya


Safe medicines project - phase II : the Zambian case study

March 2009

Expand view

This bulletin reports on the results of a study in which a range of antimalarial drugs were procured from private pharmacies, shops and kiosks within the urban and peri-urban areas of Lusaka, Zambia and tested to measure the active pharmaceutical ingredient content against internationally acceptable standards

Journal articles

Action from the grassroots to parliament : access to essential medicines gets an airing in Zambia

CHOTA, Lazarus
et al
January 2010

Expand view

The unique position of stakeholders participating in the Medicines Transparency Alliance Zambia, means that the group are able to initiate discussions at many levels from grassroots to parliament. This is of great value in highlighting critical issues about the lack of access to essential medicines experienced by many citizens in Zambia and makes progress towards finding some solutions

Antimalarial drug quality in the most severely malarious parts of Africa - a six country study

BATE, Roger
et al
May 2008

Expand view

This article describes research conducted on a range of antimalarial drugs, procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries which were subjected to semi-quantitative thin-layer chromatography (TLC) and dissolution testing to measure active pharmaceutical ingredient content against internationally acceptable standards